Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Digoxin toxicity presenting as encephalopathy

J R Greenaway1, B Abuaisha, M G Bramble

  • 1Department of Medicine, Middlesbrough General Hospital, Cleveland, UK.

Postgraduate Medical Journal
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers.

British journal of cancer·2014
Same author

Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme.

British journal of cancer·2012
Same author

Achieving high quality colonoscopy: using graphical representation to measure performance and reset standards.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2012
Same author

Pyoderma gangrenosum associated with collagenous colitis.

Clinical and experimental dermatology·2007
Same author

Cutaneous xanthomatosis: a novel presentation of hypercholesterolaemia in primary sclerosing cholangitis.

The British journal of dermatology·2006
Same author

Terminal ileal biopsies should not be used to document extent of colonoscopic examination.

Gut·2005

Digoxin toxicity can cause encephalopathy, a brain dysfunction, even without typical symptoms. These cases highlight the need to consider digoxin poisoning in unexplained encephalopathy.

Area of Science:

  • Cardiology
  • Neurology
  • Clinical Toxicology

Background:

  • Digoxin is a cardiac glycoside used for heart failure and arrhythmias.
  • Digoxin toxicity can manifest with various symptoms, including gastrointestinal, visual, and cardiac disturbances.
  • Encephalopathy, a brain dysfunction, is a less common but serious manifestation of digoxin toxicity.

Observation:

  • Two cases of digoxin toxicity presented with encephalopathy.
  • Electroencephalography (EEG) supported the diagnosis of encephalopathy.
  • Other common signs of digoxin toxicity were absent.

Findings:

  • Encephalopathy can be a primary manifestation of digoxin toxicity.
  • EEG findings may indicate digoxin-induced brain dysfunction.

Related Experiment Videos

  • The absence of other symptoms can complicate diagnosis.

    • Implications:

    • Clinicians should consider digoxin toxicity in unexplained encephalopathy.
    • EEG may be a valuable tool in diagnosing digoxin-induced neurological effects.
    • This presentation broadens the understanding of digoxin toxicity's clinical spectrum.